Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00585975Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bromfenac sodium in post-operative ocular inflammation, post-operative ocular pain, sponsored by Bausch + Lomb. Started Oct 2007; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT00585975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585975.